27 June 2024
Asia GP-led secondaries: A new normal for liquidity?
GP-led secondaries have become a more attractive, alternative, path to liquidity amid a challenging exit environment for sponsors during the past two years. While APAC markets still lag behind their Western counterparts in terms of utilising this type of transaction, recent completed transactions have been encouraging.
In BDA’s latest insight piece, we share our key thoughts on the Asian GP-Led secondaries landscape:
- Continuation Fund transactions, established in the US and Europe, are growing in Asia, with notable activity in Japan, India, China and SE Asia
- Market volatility and challenging exits are driving more sponsors to the secondaries market
- Secondary investors prioritise GP-alignment, growth and resilience; however macro-economic and political uncertainties, particularly in China, have lead to a pricing gap and a more cautious investment
- Secondary funds “dry powder” remains high and investors are focusing on well-performing assets, strong GP-alignment and recession resilience
Download the full report for more insights on the Asian GP-led secondaries
Contacts
Latest insights
25 April 2025
BDA’s Jeff Acton quoted in Bloomberg on Japan’s overseas M&A...
Bloomberg has featured commentary from BDA Partners in its latest article...
21 April 2025
Women’s health matters: Unlocking investment opportunities beyond...
In 2023, the global women’s health market was valued at US$250-300...
17 April 2025
Southeast Asia Healthcare Distribution: Delivering value
We assessed both the medical devices (Medtech) and pharmaceutical...
9 April 2025
Wind thought piece – Onshore tailwinds
The global wind industry is entering a new era of growth. The need to triple...